Laise, P., Bosker, G., Babor, M., Sun, X., Andrews, S., Tomassoni, L., Califano, A., & Alvarez, M. (2025). Systematic identification and targeting of master regulator checkpoints (MRC) governing tumor microenvironment-mediated immune evasion. Journal for ImmunoTherapy of Cancer, 13(6), e011355. https://doi.org/10.1136/jitc-2024-011355

Makamo, N., Schoon, S., Ozuah, N., Kaspers, G., Ladas, E. J., & Huibers, M. (2025). Prevalence of undernutrition in children with cancer in low-income and middle-income countries: a systematic review. BMJ Global Health, 10(6), e019345. https://doi.org/10.1136/bmjgh-2025-019345

Marxer, C. A., Ebrahimi, F., Bergman, D., Sun, J., Hagström, H., Thuresson, M., Stephansson, O., & Ludvigsson, J. F. (2025). Mortality and Cancer in Offspring of Mothers With Biopsy‐Proven MASLD During Pregnancy: A Nationwide Cohort Study. Liver International, 45(7). Portico. https://doi.org/10.1111/liv.70174

Zhou, Q., Siegelin, M. D., & Greene, L. A. (2025). Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity. Cells, 14(9), 667. https://doi.org/10.3390/cells14090667

Tao, J. J., Setton, J., Sánchez Vela, P., Safonov, A. M., Comen, E. A., Braunstein, L. Z., Reis-Filho, J. S., Riaz, N., Powell, S. N., Levine, R. L., Norton, L., Razavi, P., & Khan, A. J. (2025). Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy. JCO Precision Oncology, 9. https://doi.org/10.1200/po-24-00548

Gevertz, J. L., Greene, J. M., Prosperi, S., Comandante-Lou, N., & Sontag, E. D. (2025). Understanding therapeutic tolerance through a mathematical model of drug-induced resistance. Npj Systems Biology and Applications, 11(1). https://doi.org/10.1038/s41540-025-00511-3

Hoffman, R. M., Wolf, A. M. D., Raoof, S., Guerra, C. E., Church, T. R., Elkin, E. B., Etzioni, R. D., Shih, Y. T., Skates, S. J., Manassaram‐Baptiste, D., & Smith, R. A. (2025). Multicancer early detection testing: Guidance for primary care discussions with patients. Cancer, 131(7). Portico. https://doi.org/10.1002/cncr.35823

Jiang, W., Jaehnig, E. J., Liao, Y., Shi, Z., Yaron-Barir, T. M., Johnson, J. L., Cantley, L. C., & Zhang, B. (2025). Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-57993-2

Wen, T., Fish, M. G., & Friedman, A. M. (2025). Trends and outcomes associated with cancer diagnoses during delivery hospitalizations. Seminars in Perinatology, 49(2), 152046. https://doi.org/10.1016/j.semperi.2025.152046

Gupta, A., Till, C., Vaidya, R., Hershman, D. L., & Unger, J. M. (2025). Health Care Contact Days for Older Adults Enrolled in Cancer Clinical Trials. JAMA Network Open, 8(3), e250778. https://doi.org/10.1001/jamanetworkopen.2025.0778

Morris, Z. S., Demaria, S., Monjazeb, A. M., Formenti, S. C., Weichselbaum, R. R., Welsh, J., Enderling, H., Schoenfeld, J. D., Brody, J. D., McGee, H. M., Mondini, M., Kent, M. S., Young, K. H., Galluzzi, L., Karam, S. D., Theelen, W. S. M. E., Chang, J. Y., Huynh, M. A., Daib, A., … Fong, L. (2025). Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. The Lancet Oncology, 26(3), e152–e170. https://doi.org/10.1016/s1470-2045(24)00656-9

Tannock, I. F., de Vries, E. G. E., Fojo, A., Buyse, M., & Moja, L. (2025). Dose optimisation to improve access to effective cancer medicines. The Lancet Oncology, 26(3), e171–e180. https://doi.org/10.1016/s1470-2045(24)00648-x

Petrillo, L. A., Hsu, K., Pintro, K., Rabideau, D. J., Zhou, A. Z., Sarathy, R., Tran, A., Sullivan, R., Reynolds, K. L., El-Jawahri, A., Volandes, A., Greer, J. A., & Temel, J. S. (2025). Pilot Randomized Trial of an Educational Intervention About Immunotherapy for Patients With Advanced Cancer and Their Caregivers. Journal of the National Comprehensive Cancer Network, 23(2), 12–20. https://doi.org/10.6004/jnccn.2024.7079

Wu, L. W., Moy, R. H., Bhardwaj, N., Cho, K., Feng, G.-S., Kim, E. S., Lei, M., Liu, E. T., Maitra, A., Mori, M., Ng, I. O. L., Oshima, M., Pao, W., Park, B. H., Ramalingam, S., Rha, S. Y., Ryeom, S. W., Shaw, A. T., … Yang, J. C.-H. (2025). Strengthening Asian/Asian American, Native Hawaiian, and Pacific Islander Leadership in Cancer Research. Cancer Discovery, 15(2), 267–270. https://doi.org/10.1158/2159-8290.cd-24-1618

Borck, P. C., Boyle, I., Jankovic, K., Bick, N., Foster, K., Lau, A. C., Parker-Burns, L. I., Lubicki, D. A., Li, T., Borah, A. A., Lofaso, N. J., Das Sharma, S., Chan, T., Kishen, R. V., Adeagbo, A., Raghavan, S., Aquilanti, E., Prensner, J. R., Krill-Burger, J. M., … Vazquez, F. (2025). SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO. Nature, 638(8052), 1104–1111. https://doi.org/10.1038/s41586-024-08509-3

Beauchemin, M. P., Walker, D., Rosen, A., Frazer, M., Eisenberger, M., Khurana, R. K., Bentlyewski, E., Fedorko, V., Basch, C. H., & Hillyer, G. C. (2025). Insights From Diverse Perspectives on Social Media Messages to Inform Young Adults With Cancer About Clinical Trials: Focus Group Study. JMIR Formative Research, 9, e64265–e64265. https://doi.org/10.2196/64265

Luke, J. J., Sweis, R. F., Hecht, J. R., Schneider, R., Stein, M. N., Golan, T., Yap, T. A., Khilnani, A., Huang, M., Zhao, R., Jemielita, T., & Patel, S. P. (2025). Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas. Clinical Cancer Research, 31(7), 1233–1242. https://doi.org/10.1158/1078-0432.ccr-24-2824

Kang, S. K., Gulati, R., Moise, N., Hur, C., & Elkin, E. B. (2025). Multi-Cancer Early Detection Tests: State of the Art and Implications for Radiologists. Radiology, 314(1). https://doi.org/10.1148/radiol.233448

Slatnick, L. R., Hoogstra, D., Fisher, B. T., Wolf, J., Orgel, E., Nessle, C. N., Patel, P. A., Miller, T. P., Wilkes, J., Dupuis, L. L., Goode, E., Jackson, K., Willis, D. N., Elgarten, C., Aftandilian, C., Thompson, J., Alexander, S., Beauchemin, M. P., Belsky, J. A., … Esbenshade, A. J. (2025). Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children’s Oncology Group Institutions. Pediatric Blood & Cancer, 72(3). Portico. https://doi.org/10.1002/pbc.31532

Perumal, N., Gopalakrishnan, P., Burkovetskaya, M., Doss, D., Dukkipati, S. S., Kanchan, R. K., & Mahapatra, S. (2025). Nuclear factor I/B: Duality in action in cancer pathophysiology. Cancer Letters, 609, 217349. https://doi.org/10.1016/j.canlet.2024.217349

Brown, A. R., Hirschhorn, T., & Stockwell, B. R. (2024). Ferroptosis—disease perils and therapeutic promise. Science, 386(6724), 848–849. https://doi.org/10.1126/science.adn7030

Yang, X., Liu, Y., Wang, Z., Jin, Y., & Gu, W. (2024). Ferroptosis as a new tool for tumor suppression through lipid peroxidation. Communications Biology, 7(1). https://doi.org/10.1038/s42003-024-07180-8

Silva, R. B., Cheng, B., Carvajal, R. D., & Lee, S. M. (2024). Dose Individualization for Phase I Cancer Trials With Broadened Eligibility. Statistics in Medicine, 43(29), 5534–5547. Portico. https://doi.org/10.1002/sim.10264

Navi, B. B., Zhang, C., Miller, B. R., Pawar, A., Cushman, M., Kasner, S. E., Tirschwell, D., Longstreth, W. T., Kronmal, R., Elm, J., Zweifler, R. M., Tarsia, J., Broderick, J. P., Gladstone, D. J., Beyeler, M., Kamel, H., Elkind, M. S. V., & Streib, C. (2024). Diagnosis of Incident Cancer After Cryptogenic Stroke. Neurology, 103(10). https://doi.org/10.1212/wnl.0000000000210027

Redenti, A., Im, J., Redenti, B., Li, F., Rouanne, M., Sheng, Z., Sun, W., Gurbatri, C. R., Huang, S., Komaranchath, M., Jang, Y., Hahn, J., Ballister, E. R., Vincent, R. L., Vardoshivilli, A., Danino, T., & Arpaia, N. (2024). Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature, 635(8038), 453–461. https://doi.org/10.1038/s41586-024-08033-4

Beddok, A., Orlhac, F., Rozenblum, L., Calugaru, V., Créhange, G., Dercle, L., Nioche, C., Thariat, J., Marin, T., El Fakhri, G., & Buvat, I. (2024). Radiomics-driven personalized radiotherapy for primary and recurrent tumors: A general review with a focus on reirradiation. Cancer/Radiothérapie, 28(6–7), 597–602. https://doi.org/10.1016/j.canrad.2024.09.002

Chen, J., Dalerba, P., Terry, M. B., & Yang, W. (2024). Global obesity epidemic and rising incidence of early-onset cancers. Journal of Global Health, 14. https://doi.org/10.7189/jogh.14.04205

Taylor, A. M. (2024). Cancer Genomes Sometimes Take the Longest Evolutionary Road. Cancer Discovery, 14(10), 1766–1767. https://doi.org/10.1158/2159-8290.cd-24-1017

Marchak, J. G., Beauchemin, M. P., Broglie, L., Kelly, K. P., Seelisch, J., & Dupuis, L. L. (2024). Impact of the Children’s Oncology Group’s supportive care clinical practice guideline endorsement program: An institutional survey. Pediatric Blood & Cancer, 71(10). Portico. https://doi.org/10.1002/pbc.31178

Sugalski, A. J., Grimes, A. C., Nuño, M. M., Ramakrishnan, S., Beauchemin, M. P., Robinson, P. D., Santesso, N., Walsh, A. M., Wrightson, A. R., Yu, L. C., Parsons, S. K., Sung, L., & Dupuis, L. L. (2024). Clinical practice guideline‐inconsistent chemotherapy‐induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children’s Oncology Group study. Pediatric Blood & Cancer, 71(11). Portico. https://doi.org/10.1002/pbc.31295

Winestone, L. E., Wilkes, J. J., Puccetti, D., Keegan, T. H. M., Henk, H. J., McPheeters, J., Kahn, J. M., Ginsberg, J., Wong, S., Timberline, S., Malogolowkin, M., Pollock, B. H., & Alvarez, E. (2024). Time to diagnosis among young patients with cancer. Pediatric Blood & Cancer, 71(9). Portico. https://doi.org/10.1002/pbc.30997

Gretarsson, K. H., Abini-Agbomson, S., Gloor, S. L., Weinberg, D. N., McCuiston, J. L., Kumary, V. U. S., Hickman, A. R., Sahu, V., Lee, R., Xu, X., Lipieta, N., Flashner, S., Adeleke, O. A., Popova, I. K., Taylor, H. F., Noll, K., Windham, C. L., Maryanski, D. N., Venters, B. J., … Lu, C. (2024). Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch. Science Advances, 10(35). https://doi.org/10.1126/sciadv.adp0975

Di Bona, M., Chen, Y., Agustinus, A. S., Mazzagatti, A., Duran, M. A., Deyell, M., Bronder, D., Hickling, J., Hong, C., Scipioni, L., Tedeschi, G., Martin, S., Li, J., Ruzgaitė, A., Riaz, N., Shah, P., D’Souza, E. K., Brodtman, D. Z., Sidoli, S., … Bakhoum, S. F. (2024). Micronuclear collapse from oxidative damage. Science, 385(6712). https://doi.org/10.1126/science.adj8691

Navi, B. B., Zhang, C., Miller, B., Cushman, M., Kasner, S. E., Elkind, M. S. V., Tirschwell, D. L., Longstreth, W. T., Kronmal, R. A., Beyeler, M., Elm, J., Zweifler, R. M., Tarsia, J., Cereda, C. W., Bianco, G., Costamagna, G., Michel, P., Broderick, J. P., Gladstone, D. J., … Streib, C. (2024). Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke. JAMA Neurology, 81(9), 958. https://doi.org/10.1001/jamaneurol.2024.2404

Fu, X., & Rabadan, R. (2024). Understanding variants of unknown significance: the computational frontier. The Oncologist, 29(8), 653–657. https://doi.org/10.1093/oncolo/oyae103

Kehm, R. D., Li, J., & Cone, J. E. (2024). Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer. Cancer Medicine, 13(16). Portico. https://doi.org/10.1002/cam4.70071

Furtado, L. V., Bifulco, C., Dolderer, D., Hsiao, S. J., Kipp, B. R., Lindeman, N. I., Ritterhouse, L. L., Temple-Smolkin, R. L., Zehir, A., & Nowak, J. A. (2024). Recommendations for Tumor Mutational Burden Assay Validation and Reporting. The Journal of Molecular Diagnostics, 26(8), 653–668. https://doi.org/10.1016/j.jmoldx.2024.05.002

Schoeman, J., Kellerman, I.-M., Ladas, E. J., Ndlovu, S., Rogers, P. C., du Plessis, J., Herholdt, M., Reynders, D. T., Naidu, G., Rowe, B., Thomas, K., Vanemmenes, B., Mathews, R., Büchner, A., Omar, F. E., Ronelle, U., & Kruger, M. (2024). Implemented nutritional intervention algorithm in pediatric oncology compared to standard nutritional supportive care outcomes. Clinical Nutrition ESPEN, 63, 870–877. https://doi.org/10.1016/j.clnesp.2024.08.019

Basu, A., & Hershman, D. L. (2024). The “PRO”mise and “PRO”gress of PROs in cancer clinical trials. JNCI: Journal of the National Cancer Institute, 116(10), 1544–1546. https://doi.org/10.1093/jnci/djae157

NAGINI, S., KALLAMADI, P. R., TANAGALA, K. K. K., & REDDY, G. B. (2024). Aldo-keto reductases: Role in cancer development and theranostics. Oncology Research, 32(8), 1287–1308. https://doi.org/10.32604/or.2024.049918

Kehm, R. D. (2024). Continued prioritization of biomedical research over sociomedical research may widen disparities in cancer outcomes. JNCI: Journal of the National Cancer Institute, 116(10), 1547–1548. https://doi.org/10.1093/jnci/djae150

Pohl, S. A., Nelson, B. A., Patwary, T. R., Amanuel, S., Benz, E. J., & Lathan, C. S. (2024). Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey. CA: A Cancer Journal for Clinicians, 74(4), 383–396. Portico. https://doi.org/10.3322/caac.21841

Sidhu, M. S., Gokhroo, G., Mulinti, S., Pati, M. B., Murali, M., Gupta, V., Chaudhari, S., Rayn, K., & Beriwal, S. (2024). Pilot study of radiation oncology peer review in low middle income country (LMIC) through cloud-based platform. Journal of Cancer Research and Therapeutics, 20(5), 1591–1594. https://doi.org/10.4103/jcrt.jcrt_1697_23

Efe, G., Rustgi, A. K., & Prives, C. (2024). p53 at the crossroads of tumor immunity. Nature Cancer, 5(7), 983–995. https://doi.org/10.1038/s43018-024-00796-z

Takvorian, S. U., Gabriel, P., Wileyto, E. P., Blumenthal, D., Tejada, S., Clifton, A. B. W., Asch, D. A., Buttenheim, A. M., Rendle, K. A., Shelton, R. C., Chaiyachati, K. H., Fayanju, O. M., Ware, S., Schuchter, L. M., Kumar, P., Salam, T., Lieberman, A., Ragusano, D., Bauer, A.-M., … Parikh, R. B. (2024). Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk. JAMA Network Open, 7(7), e2418639. https://doi.org/10.1001/jamanetworkopen.2024.18639

Navi, B. B., Zhang, C., Kaiser, J. H., Liao, V., Cushman, M., Kasner, S. E., Elkind, M. S. V., Tagawa, S. T., Guntupalli, S. R., Gaudino, M. F. L., Lee, A. Y. Y., Khorana, A. A., & Kamel, H. (2023). Cancer and the risk of perioperative arterial ischaemic events. European Heart Journal - Quality of Care and Clinical Outcomes, 10(4), 345–356. https://doi.org/10.1093/ehjqcco/qcad057

Baniasadi, A., Das, J. P., Prendergast, C. M., Beizavi, Z., Ma, H. Y., Jaber, M. Y., & Capaccione, K. M. (2024). Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05379-1

Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024). Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell, 42(6), 946–967. https://doi.org/10.1016/j.ccell.2024.04.009

Eschliman, E. L., Hoang, D., Khoshnam, N., Ye, V., Kokaze, H., Ji, Y., Zhong, Y., Morumganti, A., Xi, W., Huang, S., Choe, K., Poku, O. B., Alvarez, G., Nguyen, T., Nguyen, N. T., Shelley, D., & Yang, L. H. (2024). A “What Matters Most” approach to investigating intersectional stigma toward HIV and cancer in Hanoi, Vietnam. JNCI Monographs, 2024(63), 11–19. https://doi.org/10.1093/jncimonographs/lgae002